Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1)
Crossref DOI link: https://doi.org/10.1208/s12248-016-9904-3
Published Online: 2016-03-30
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Aman P.
Maass, Katie F.
Betts, Alison M.
Wittrup, K. Dane
Kulkarni, Chethana
King, Lindsay E.
Khot, Antari
Shah, Dhaval K.
Text and Data Mining valid from 2016-03-30